PSTV
Plus Therapeutics
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Cerenome secured an in-network agreement with Health Care Service Corporation, expanding CNSide contracted coverage to more than 150 million covered livesAug 13, 2026
- Plus Therapeutics highlighted updated NCCN CNS cancer guidelines reinforcing the clinical role of CNSide in monitoring leptomeningeal metastasesJul 14, 2026
- Plus Therapeutics receives Medicare enrollment approval for CNSide diagnosticMay 7, 2026
- Plus Therapeutics started manufacturing activities with SpectronRx to support GMP readiness for the pivotal REYOBIQ trialApr 23, 2026
- Plus Therapeutics received FDA orphan drug designation for REYOBIQ in pediatric malignant gliomasApr 8, 2026